Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Learn about the credit cards that provide the best travel perks, ensuring you get the most value for your adventures.
24,034 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
NVIDIA just crushed earnings on the headline numbers, yet the stock reacted oddly, slipping the next day. This guide ...
A new revenue milestone in space markets signals a shift toward recurring income streams. Three ETFs are taking inves...
Snowflake beat estimates, raised its full-year outlook, and committed $6 billion to expand collaboration with AWS, se...
Palantir faces a steeper path in 2026 as the stock retreats, yet bulls argue the core AI platform and government dema...
Could a single crypto asset multiply your wealth over 10 years? This article lays out a practical, data-driven look a...
Bitcoin faces first jobs-week as US labor data lands ahead of payrolls, guiding Fed bets and crypto volatility. Inves...
Christie’s New York Spring Auction Week posted $1.45 billion in sales, led by a Pollock that fetched $181 million. Th...
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Micron ralled dramatically in May as memory chips rode AI and data-center demand. This deep dive explains what fueled...
The Amplify Seymour Cannabis ETF (CNBS) is up 105% over the past year, driven by investor bets on federal cannabis re...
A key on-chain signal points to a potential drop toward $700 for ethereum (eth), even as network activity grows and i...